News

Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...
Florida state lawmakers have approved a bill to ban the addition of fluoride to public drinking water, a move that public health experts say could harm dental health across the state.
Environmental Health Perspectives, a journal funded by the National Institutes of Health (NIH), announced that it would pause new submissions.
The replicate confirmatory KALOS and LOGOS trials evaluated BGF in participants with severe asthma inadequately controlled with standard of care.
The review extension was needed as the FDA required time to review Cytokinetics’ proposed Risk Evaluation and Mitigation Strategy (REMS).
The Food and Drug Administration (FDA) has cleared the Jewel ® Patch Wearable Cardioverter Defibrillator (Patch-WCD) for adult patients aged 18 years and older who are at risk for sudden cardiac ...
Combined use of SGLT2 inhibitors and GLP-1 receptor agonists also significantly increased the risk for falls. HealthDay News — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent ...
The FDA is expected to decide on treatments for bullous pemphigoid, hereditary angioedema, HIV PrEP, ovarian cancer, and RSV.
Measles may reestablish endemicity, with an estimated 851,300 cases over 25 years at current vaccination rates.
Children receiving multiple antibiotic courses between birth and age 2 years may have a higher risk for some chronic conditions.
Urcosimod is a lipid conjugated ChemR23 chemerin peptide agonist that is designed to reduce inflammation and pain in the eye.
HealthDay News — For patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL), statin use is associated with improved survival, regardless of treatment employed, according ...